We Need your help

Have you had a deep vein thrombosis (blood clot in the legs) or a pulmonary embolism (blood clot on the lungs) either while you were in hospital or shortly after being discharged? Or has this happened to a relative of yours?

Over 25,000 people die every year following a DVT or PE after a stay in hospital.

AntiCoagulation Europe is producing an educational programme to highlight the risks of DVT and PE and needs to talk to people who have had this experience, or to relatives of those who have died.

Please help us to help others. Email your story in the first instance to anticoagulation@ntlworld.com

Welcome to the Anticoagulation Europe web site

We hope you will find it interesting and useful.

We always welcome feedback and value your opinions, so please let us know if you have any comments or suggestions about the site.

You will find out a little more about who we are at About Us.

AntiCoagulation Europe is collaborating with Roche Diagnostics Ltd to coordinate the CoaguNation Bus Tour

For more information see events page.

First oral anticoagulant to be licensed in over 50 years

· A daily pill that could help prevent deaths from blood clots following elective hip and knee replacement surgery has received its license

· Bloods clots or venous thrombo-embolism (VTE), cause 1 in 10 fatalities in hospital and kill at least 25,000 people in the England every year - more than 20 times the number of deaths attributed to the superbug MRSA

· The pill, called Pradaxa® (dabigatran etexilate), is the first new blood-thinning treatment to be made available as a tablet in over half a century

· Currently, many patients undergoing hip and knee replacement surgery who should receive medicines to prevent blood clots are not doing so

Many of the 130,000 UK patients who every year undergo total hip or total knee replacement are at high risk of developing a venous thrombo-embolism or VTE. VTE may occur inside a deep vein, partially or totally blocking the flow of blood - this is called a deep vein thrombosis or DVT. Without treatment to prevent VTE as many as 60 per cent of patients will develop a DVT, while up to 1 in 10 patients will develop a potentially fatal pulmonary embolism (PE), where the clot breaks loose and travels to the lungs.

Want to self test?

Having trouble getting your test strips available on prescription?

There is an ACE resource pack designed to help you - see Campaigns

Hospital-acquired DVT Guidance

In a move to reduce the 25,000 deaths a year from hospital-acquired deep vein thrombosis and pulmonary embolism, the Chief Medical officer issues his guidance on Hospital Acquired Venous Thromboembolism (deep vein thrombosis and pulmonary embolism) - see News and Developments

The National Institute for Clinical Excellence (NICE) has now issued its guidance for surgical patients - see News and Developments

LATEST UPDATE on Prescription Campaign CLICK HERE

The views and opinions expressed in the personal experiences listed on this web site are not necessarily those of AntiCoagulation Europe.

No item may be reproduced without the permission of AntiCoagulation Europe.